Video

Dr. Paulson on the Utility of Liquid Biopsies Versus Tissue Biopsies

R. Steven Paulson, MD, discusses the utility of liquid biopsies versus tissue biopsies.

R. Steven Paulson, MD, physician, Texas Oncology, discusses the utility of liquid biopsies versus tissue biopsies.

Although tissue biopsy remains the gold standard in oncology, there may not be enough available tissue to perform a biopsy, explains Paulson. In these cases, a patient may need to undergo an invasive procedure to retrieve more tissue for testing.

Alternatively, a liquid biopsy may alleviate the need for an invasive procedure since it only requires a blood draw, says Paulson. A positive result with a liquid biopsy is relatively reliable; however, a negative test result should not be considered definitive.

Additionally, the turn-around time for a liquid biopsy is faster than a tissue biopsy. Therefore, if a liquid biopsy is positive, patients can begin targeted therapy earlier. However, the interpretation of liquid biopsies requires some standardization, concludes Paulson.

Newsletter

Stay up to date on the most recent and practice-changing oncology data

Latest CME

View All
Medical Crossfire®: Expert Perspectives on Targeting c-Met Overexpression and 𝘔𝘌𝘛 Genomic Alterations in NSCLC – Unveiling the Complexities of 𝘔𝘌𝘛 Dysregulation
Video

Medical Crossfire®: Expert Perspectives on Targeting c-Met Overexpression and 𝘔𝘌𝘛 Genomic Alterations in NSCLC – Unveiling the Complexities of 𝘔𝘌𝘛 Dysregulation

Jun 6th 2025 - Jul 12th 2025

online-activity
Tumor Board: Expert Insights on Managing Classical 𝘌𝘎𝘍𝘙 Mutations, 𝘌𝘎𝘍𝘙 Exon 20 Insertions, and Atypical 𝘌𝘎𝘍𝘙 Mutations in Metastatic NSCLC
Video

Tumor Board: Expert Insights on Managing Classical 𝘌𝘎𝘍𝘙 Mutations, 𝘌𝘎𝘍𝘙 Exon 20 Insertions, and Atypical 𝘌𝘎𝘍𝘙 Mutations in Metastatic NSCLC

Jun 6th 2025 - Jul 12th 2025

online-activity
Evolving Treatment Strategies in Pancreatic Cancer: Current Standards, Emerging Targets, and the Role of Molecular Testing
Video

Evolving Treatment Strategies in Pancreatic Cancer: Current Standards, Emerging Targets, and the Role of Molecular Testing

Jun 5th 2025 - Jul 12th 2025

online-activity